Kite Pharma, Inc. (NASDAQ:KITE) belongs to Healthcare sector. Its weekly performance is 6.84%. On last trading day company shares ended up $69.78. Kite Pharma, Inc. (NASDAQ:KITE) distance from 50-day simple moving average (SMA50) is 21.75%. On 2 July, Kite Pharma, Inc. (NASDAQ:KITE) has struck yet another deal – the company entered into a collaboration agreement with The Leukemia & Lymphoma Society (LLS) for the development of its lead pipeline candidate, KTE-C19, for the treatment of patients with refractory aggressive non-Hodgkin lymphoma (NHL).
Groupon, Inc. (NASDAQ:GRPN) shares moved up 5.37% in last trading session and ended the day at $5.10. GRPN Gross Margin is 47.40% and its return on assets is -2.30%. Groupon, Inc. (NASDAQ:GRPN) quarterly performance is -29.66%. On 7 July, Groupon Inc. (NASDAQ:GRPN) launched an epic sweepstakes for a trip for two to New Orleans to meet renowned chef, restaurateur and television personality Emeril Lagasse. Starting 7 July and running through July 15, Groupon users can enter the sweepstakes by either visiting www.groupon.com/emeril to make a $10 donation to the Emeril Lagasse Foundation or for free by mail.
On 13 July, Enphase Energy, Inc. (NASDAQ:ENPH) shares moved up 5.68% and was closed at $6.33. ENPH EPS growth in last 5 year was 15.10%. Enphase Energy, Inc. (NASDAQ:ENPH) year to date (YTD) performance is -55.70%. On 9 July, Enphase Energy, Inc. (NASDAQ:ENPH) has entered a strategic partnership with Wocozon BV, a Dutch nonprofit service company that provides renewable energy services to social housing projects. Wocozon will install solar photovoltaic (PV) arrays equipped with Enphase® solar energy systems on 2,700 homes in multiple social housing dwellings across the Netherlands.
Sequenom Inc. (NASDAQ:SQNM) ended the last trading day at $3.18. Company weekly volatility is calculated as 6.48% and price to cash ratio as 4.14. Sequenom Inc. (NASDAQ:SQNM) showed a weekly performance of 6.71%. Sequenom Laboratories, a wholly owned subsidiary of Sequenom, Inc., (NASDAQ:SQNM) a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced the upcoming launch of the MaterniT GENOME laboratory-developed test. This test is the first noninvasive prenatal test (NIPT) to provide karyotype-level insight into fetal chromosomal status prior to considering an invasive procedure.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) shares moved up 7.99% in last trading session and ended the day at $67.19. ANIP Gross Margin is 81.80% and its return on assets is 18.00%. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) quarterly performance is -0.13%.ANI Pharmaceuticals Inc. (NASDAQ:ANIP) announced Monday that is has scooped up 22 generic drugs from Teva Pharmaceutical Industries Ltd. for a total purchase price of $25 million.